Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Pfizer |
---|---|
Information provided by: | Pfizer |
ClinicalTrials.gov Identifier: | NCT00620867 |
To compare the efficacy and safety of celecoxib versus ibuprofen in subjects with osteoarthritis (OA) of the knee.
Condition | Intervention | Phase |
---|---|---|
Osteoarthritis, Knee |
Drug: Ibuprofen Drug: celecoxib Other: placebo |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Study of the Efficacy and Tolerability of Once Daily Celebrex (Celecoxib) and Three Times Daily Ibuprofen vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee |
Enrollment: | 393 |
Study Start Date: | October 2002 |
Study Completion Date: | March 2003 |
Primary Completion Date: | March 2003 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Ibuprofen: Experimental |
Drug: Ibuprofen
800 mg oral tablet three time daily with meals for 6 weeks
|
Celecoxib: Experimental |
Drug: celecoxib
200 mg oral capsule once daily with morning meal for 6 weeks
|
placebo: Placebo Comparator |
Other: placebo
matched placebo orally for 6 weeks
|
Ages Eligible for Study: | 40 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study Director: | Pfizer CT.gov Call Center | Pfizer |
Responsible Party: | Pfizer, Inc. ( Director, Clinical Trial Disclosure Group ) |
Study ID Numbers: | A3191063 |
Study First Received: | February 12, 2008 |
Last Updated: | November 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00620867 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Anti-Inflammatory Agents Ibuprofen Celecoxib Osteoarthritis Joint Diseases Cyclooxygenase Inhibitors Rheumatic Diseases Osteoarthritis, Knee |
Musculoskeletal Diseases Analgesics, Non-Narcotic Arthritis Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents |
Anti-Inflammatory Agents Ibuprofen Celecoxib Molecular Mechanisms of Pharmacological Action Osteoarthritis Joint Diseases Cyclooxygenase Inhibitors Physiological Effects of Drugs Enzyme Inhibitors Rheumatic Diseases Pharmacologic Actions |
Osteoarthritis, Knee Musculoskeletal Diseases Analgesics, Non-Narcotic Sensory System Agents Therapeutic Uses Arthritis Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |